Posts by Sharl Azar, MD
-
Mass General to Serve as Authorized Treatment Center for First Gene Therapy for Sickle Cell Disease
The Comprehensive Sickle Cell Disease Treatment Center at Massachusetts General Hospital will serve as an authorized treatment center for an FDA-approved gene therapy for sickle cell disease.
Biography
Sharl Azar, MD, is a hematologist, medical director of the Comprehensive Sickle Cell Disease Treatment Center, and Robert K. Kraft Endowed Chair in Community Health at Massachusetts General Hospital. Dr. Azar is also an instructor in medicine at Harvard Medical School. He received his medical degree from Oregon Health & Science University where he also completed his residency in internal medicine and his fellowship in hematology and medical oncology while also serving as Chief Fellow. He went on to complete an advanced fellowship in hemostasis and thrombosis at the University of California, San Diego. Dr. Azar is passionate about the care of patients with Sickle Cell Disease, Thalassemia, and other hemoglobin disorders. His work focuses on improving systems of care and political advocacy for patients living with sickle cell disease to build a true medical home while combatting inequities in health care. He also sees patients with bleeding and clotting disorders, disorders red cell and platelet function, and hemolysis.
Follow Dr. Azar on Twitter: @TheSickleDoc
